Insider transactions

EDGAR

MannKind Corporation

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-18.

Open-market purchases (code P)
1 transactions, 100,000 shares
Sum of shares × price per share: 259,000
Open-market sales (code S)
13 transactions, 618,853 shares
Sum of shares × price per share: 3,161,297.57

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 108

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-09-25 Filed 2026-09-28Binder Steven B. Director
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 Par Value
Disposed (D)39,0513.29
128,477.79

Derived: shares × price per share. Exact value 128477.79.

713,258Direct (D) Yes
F1, F2
  • F1 Transaction occurred pursuant to Rule 10B5-1 Plan established December 2, 2025.
  • F2 The weighted average sales price of the reported transaction was $3.29 based on a range of prices between $3.20 and $3.36. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0001193125-26-405736 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-14Binder Steven B. Director
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 Par Value
Disposed (D)33,5583.81
127,855.98

Derived: shares × price per share. Exact value 127855.98.

752,309Direct (D) Yes
F1, F2
  • F1 Transaction occurred pursuant to Rule 10B5-1 Plan established December 2, 2025.
  • F2 The weighted average sales price of the reported transaction was $3.81 based on a range of prices between $3.76 and $3.87. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0001193125-26-391003 Read from the filing’s XML Dispute this row
2026-08-07 Filed 2026-08-10Binder Steven B. Director
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 Par Value
Disposed (D)39,0514.06
158,547.06

Derived: shares × price per share. Exact value 158547.06.

785,867Direct (D) Yes
F2, F1
  • F2 The weighted average sales price of the reported transaction was $4.06 based on a range of prices between $3.86 and $4.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • F1 Transaction occurred pursuant to Rule 10B5-1 Plan established December 2, 2025.
Open filing 0001193125-26-343016 Read from the filing’s XML Dispute this row
2026-07-17 Filed 2026-07-17Thomson David Officer: EVP Genl Counsel Secretary
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 Par Value
Disposed (D)24,1094.05
97,641.45

Derived: shares × price per share. Exact value 97641.45.

797,554Direct (D) Yes
F4, F3
  • F4 The weighted average sales price of the reported transaction was $4.05 based on a range of prices between $3.98 and $4.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • F3 Transaction occurred pursuant to Rule 10B5-1 Plan established December 2, 2025.
Open filing 0001193125-26-308131 Read from the filing’s XML Dispute this row
2026-07-17 Filed 2026-07-17Binder Steven B. Director
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 Par Value
Disposed (D)52,4854.06
213,089.1

Derived: shares × price per share. Exact value 213089.10.

824,918Direct (D) Yes
F4, F3
  • F4 The weighted average sales price of the reported transaction was $4.06 based on a range of prices between $3.98 and $4.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • F3 Transaction occurred pursuant to Rule 10B5-1 Plan established December 2, 2025.
Open filing 0001193125-26-308129 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Thomson David Officer: EVP Genl Counsel Secretary
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock, $0.01 Par Value
Acquired (A)93,7900—920,089Direct (D) Yes
F1
  • F1 A previously reported restricted stock unit award granted on May 25, 2023 vested on July 15, 2026 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on June 30, 2026 was not less than the closing price on May 25, 2023 and (ii) MannKind's total shareholder return (TSR) over the period from May 23, 2023 to June 30, 2026 was at the 41.5th percentile of the TSR of the Russell 3000 Pharmaceutical Biotechnology Index over the same period. As a result, the performance objective was achieved at 83% of target, resulting in a total share delivery of 93,790 shares. The acquisition of 113,000 shares pursuant to the restricted stock award was reported in Table II of the Form 4 filed by the Reporting Person on May 26, 2023. The remaining 19,210 shares were forfeited in accordance with the performance vesting criteria.
Open filing 0001193125-26-308131 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Thomson David Officer: EVP Genl Counsel Secretary
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)51,6324.09
211,174.88

Derived: shares × price per share. Exact value 211174.88.

868,457Direct (D) Yes
F2
  • F2 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Open filing 0001193125-26-308131 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Thomson David Officer: EVP Genl Counsel Secretary
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)12,6624.09
51,787.58

Derived: shares × price per share. Exact value 51787.58.

855,795Direct (D) Yes
F2
  • F2 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Open filing 0001193125-26-308131 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Thomson David Officer: EVP Genl Counsel Secretary
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)17,7544.09
72,613.86

Derived: shares × price per share. Exact value 72613.86.

838,041Direct (D) Yes
F2
  • F2 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Open filing 0001193125-26-308131 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Thomson David Officer: EVP Genl Counsel Secretary
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)16,3784.09
66,986.02

Derived: shares × price per share. Exact value 66986.02.

821,663Direct (D) Yes
F2
  • F2 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Open filing 0001193125-26-308131 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Thomson David Officer: EVP Genl Counsel Secretary
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Performance Restricted Stock Unit — underlying Common Stock, $0.01 Par Value (93,790)
Disposed (D)93,7900—0Direct (D) Yes
F5, F1
  • F5 Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
  • F1 A previously reported restricted stock unit award granted on May 25, 2023 vested on July 15, 2026 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on June 30, 2026 was not less than the closing price on May 25, 2023 and (ii) MannKind's total shareholder return (TSR) over the period from May 23, 2023 to June 30, 2026 was at the 41.5th percentile of the TSR of the Russell 3000 Pharmaceutical Biotechnology Index over the same period. As a result, the performance objective was achieved at 83% of target, resulting in a total share delivery of 93,790 shares. The acquisition of 113,000 shares pursuant to the restricted stock award was reported in Table II of the Form 4 filed by the Reporting Person on May 26, 2023. The remaining 19,210 shares were forfeited in accordance with the performance vesting criteria.
Open filing 0001193125-26-308131 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Prentiss Christopher B Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)11,5724.09
47,329.48

Derived: shares × price per share. Exact value 47329.48.

329,343Direct (D) No
F1, F2
  • F1 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
  • F2 Includes 1,991 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2026.
Open filing 0001193125-26-308139 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Prentiss Christopher B Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)10,6754.09
43,660.75

Derived: shares × price per share. Exact value 43660.75.

318,668Direct (D) No
F1
  • F1 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Open filing 0001193125-26-308139 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Tross Stuart A Officer: Chief People Workpl Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock, $0.01 Par Value
Acquired (A)93,7900—1,123,950Direct (D) No
F1, F2
  • F1 A previously reported restricted stock unit award granted on May 25, 2023 vested on July 15, 2026 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on June 30, 2026 was not less than the closing price on May 25, 2023 and (ii) MannKind's total shareholder return (TSR) over the period from May 23, 2023 to June 30, 2026 was at the 41.5th percentile of the TSR of the Russell 3000 Pharmaceutical Biotechnology Index over the same period. As a result, the performance objective was achieved at 83% of target, resulting in a total share delivery of 93,790 shares. The acquisition of 113,000 shares pursuant to the restricted stock award was reported in Table II of the Form 4 filed by the Reporting Person on May 26, 2023. The remaining 19,210 shares were forfeited in accordance with the performance vesting criteria.
  • F2 Includes 4,038 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2026.
Open filing 0001193125-26-308134 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Tross Stuart A Officer: Chief People Workpl Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)33,6524.09
137,636.68

Derived: shares × price per share. Exact value 137636.68.

1,090,298Direct (D) No
F3
  • F3 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Open filing 0001193125-26-308134 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Tross Stuart A Officer: Chief People Workpl Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)8,2534.09
33,754.77

Derived: shares × price per share. Exact value 33754.77.

1,082,045Direct (D) No
F3
  • F3 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Open filing 0001193125-26-308134 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Tross Stuart A Officer: Chief People Workpl Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)11,5724.09
47,329.48

Derived: shares × price per share. Exact value 47329.48.

1,070,473Direct (D) No
F3
  • F3 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Open filing 0001193125-26-308134 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Tross Stuart A Officer: Chief People Workpl Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)12,3314.09
50,433.79

Derived: shares × price per share. Exact value 50433.79.

1,058,142Direct (D) No
F3
  • F3 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Open filing 0001193125-26-308134 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Tross Stuart A Officer: Chief People Workpl Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Performance Restricted Stock Unit — underlying Common Stock, $0.01 Par Value (93,790)
Disposed (D)93,7900—0Direct (D) No
F4, F1
  • F4 Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
  • F1 A previously reported restricted stock unit award granted on May 25, 2023 vested on July 15, 2026 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on June 30, 2026 was not less than the closing price on May 25, 2023 and (ii) MannKind's total shareholder return (TSR) over the period from May 23, 2023 to June 30, 2026 was at the 41.5th percentile of the TSR of the Russell 3000 Pharmaceutical Biotechnology Index over the same period. As a result, the performance objective was achieved at 83% of target, resulting in a total share delivery of 93,790 shares. The acquisition of 113,000 shares pursuant to the restricted stock award was reported in Table II of the Form 4 filed by the Reporting Person on May 26, 2023. The remaining 19,210 shares were forfeited in accordance with the performance vesting criteria.
Open filing 0001193125-26-308134 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Singh Sanjay R Officer: EVP Technical Operations
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock, $0.01 Par Value
Acquired (A)70,5500—525,761Direct (D) No
F1
  • F1 A previously reported restricted stock unit award granted on May 25, 2023 vested on July 15, 2026 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on June 30, 2026 was not less than the closing price on May 25, 2023 and (ii) MannKind's total shareholder return (TSR) over the period from May 23, 2023 to June 30, 2026 was at the 41.5th percentile of the TSR of the Russell 3000 Pharmaceutical Biotechnology Index over the same period. As a result, the performance objective was achieved at 83% of target, resulting in a total share delivery of 70,550 shares. The acquisition of 85,000 shares pursuant to the restricted stock award was reported in Table II of the Form 4 filed by the Reporting Person on May 26, 2023. The remaining 14,450 shares were forfeited in accordance with the performance vesting criteria.
Open filing 0001193125-26-308132 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Singh Sanjay R Officer: EVP Technical Operations
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)22,0474.09
90,172.23

Derived: shares × price per share. Exact value 90172.23.

503,714Direct (D) No
F2
  • F2 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Open filing 0001193125-26-308132 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Singh Sanjay R Officer: EVP Technical Operations
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)5,3724.09
21,971.48

Derived: shares × price per share. Exact value 21971.48.

498,342Direct (D) No
F2
  • F2 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Open filing 0001193125-26-308132 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Singh Sanjay R Officer: EVP Technical Operations
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)10,0794.09
41,223.11

Derived: shares × price per share. Exact value 41223.11.

488,263Direct (D) No
F2
  • F2 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Open filing 0001193125-26-308132 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Singh Sanjay R Officer: EVP Technical Operations
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)9,2974.09
38,024.73

Derived: shares × price per share. Exact value 38024.73.

478,966Direct (D) No
F2
  • F2 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Open filing 0001193125-26-308132 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Singh Sanjay R Officer: EVP Technical Operations
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Performance Restricted Stock Unit — underlying Common Stock, $0.01 Par Value (70,550)
Disposed (D)70,5500—0Direct (D) No
F3, F1
  • F3 Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
  • F1 A previously reported restricted stock unit award granted on May 25, 2023 vested on July 15, 2026 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on June 30, 2026 was not less than the closing price on May 25, 2023 and (ii) MannKind's total shareholder return (TSR) over the period from May 23, 2023 to June 30, 2026 was at the 41.5th percentile of the TSR of the Russell 3000 Pharmaceutical Biotechnology Index over the same period. As a result, the performance objective was achieved at 83% of target, resulting in a total share delivery of 70,550 shares. The acquisition of 85,000 shares pursuant to the restricted stock award was reported in Table II of the Form 4 filed by the Reporting Person on May 26, 2023. The remaining 14,450 shares were forfeited in accordance with the performance vesting criteria.
Open filing 0001193125-26-308132 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Castagna Michael Director · Officer: Chief Executive Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock, $0.01 Par Value
Acquired (A)350,2600—2,796,979Direct (D) No
F1, F2
  • F1 A previously reported restricted stock unit award granted on May 25, 2023 vested on July 15, 2026 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on June 30, 2026 was not less than the closing price on May 25, 2023 and (ii) MannKind's total shareholder return (TSR) over the period from May 23, 2023 to June 30, 2026 was at the 41.5th percentile of the TSR of the Russell 3000 Pharmaceutical Biotechnology Index over the same period. As a result, the performance objective was achieved at 83% of target, resulting in a total share delivery of 350,260 shares. The acquisition of 422,000 shares pursuant to the restricted stock award was reported in Table II of the Form 4 filed by the Reporting Person on May 26, 2023. The remaining 71,740 shares were forfeited in accordance with the performance vesting criteria.
  • F2 Includes 4,409 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2026.
Open filing 0001193125-26-308133 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Castagna Michael Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)192,8194.09
788,629.71

Derived: shares × price per share. Exact value 788629.71.

2,604,160Direct (D) No
F3
  • F3 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Open filing 0001193125-26-308133 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Castagna Michael Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)47,4814.09
194,197.29

Derived: shares × price per share. Exact value 194197.29.

2,556,679Direct (D) No
F3
  • F3 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Open filing 0001193125-26-308133 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Castagna Michael Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)63,9964.09
261,743.64

Derived: shares × price per share. Exact value 261743.64.

2,492,683Direct (D) No
F3
  • F3 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Open filing 0001193125-26-308133 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Castagna Michael Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)58,9044.09
240,917.36

Derived: shares × price per share. Exact value 240917.36.

2,433,779Direct (D) No
F3
  • F3 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Open filing 0001193125-26-308133 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Castagna Michael Director · Officer: Chief Executive Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Performance Restricted Stock Unit — underlying Common Stock, $0.01 Par Value (350,260)
Disposed (D)350,2600—0Direct (D) No
F4, F1
  • F4 Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
  • F1 A previously reported restricted stock unit award granted on May 25, 2023 vested on July 15, 2026 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on June 30, 2026 was not less than the closing price on May 25, 2023 and (ii) MannKind's total shareholder return (TSR) over the period from May 23, 2023 to June 30, 2026 was at the 41.5th percentile of the TSR of the Russell 3000 Pharmaceutical Biotechnology Index over the same period. As a result, the performance objective was achieved at 83% of target, resulting in a total share delivery of 350,260 shares. The acquisition of 422,000 shares pursuant to the restricted stock award was reported in Table II of the Form 4 filed by the Reporting Person on May 26, 2023. The remaining 71,740 shares were forfeited in accordance with the performance vesting criteria.
Open filing 0001193125-26-308133 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Binder Steven B. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock, $0.01 Par Value
Acquired (A)93,7900—901,798Direct (D) Yes
F1
  • F1 A previously reported restricted stock unit award granted on May 25, 2023 vested on July 15, 2026 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on June 30, 2026 was not less than the closing price on May 25, 2023 and (ii) MannKind's total shareholder return (TSR) over the period from May 23, 2023 to June 30, 2026 was at the 41.5th percentile of the TSR of the Russell 3000 Pharmaceutical Biotechnology Index over the same period. As a result, the performance objective was achieved at 83% of target, resulting in a total share delivery of 93,790 shares. The acquisition of 113,000 shares pursuant to the restricted stock award was reported in Table II of the Form 4 filed by the Reporting Person on May 26, 2023. The remaining 19,210 shares were forfeited in accordance with the performance vesting criteria.
Open filing 0001193125-26-308129 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Binder Steven B. Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)15,6884.09
64,163.92

Derived: shares × price per share. Exact value 64163.92.

886,110Direct (D) Yes
F2
  • F2 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Open filing 0001193125-26-308129 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Binder Steven B. Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)4,0734.09
16,658.57

Derived: shares × price per share. Exact value 16658.57.

882,037Direct (D) Yes
F2
  • F2 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Open filing 0001193125-26-308129 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Binder Steven B. Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)4,6344.09
18,953.06

Derived: shares × price per share. Exact value 18953.06.

877,403Direct (D) Yes
F2
  • F2 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
Open filing 0001193125-26-308129 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Binder Steven B. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Performance Restricted Stock Unit — underlying Common Stock, $0.01 Par Value (93,790)
Disposed (D)93,7900—0Direct (D) Yes
F5, F1
  • F5 Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
  • F1 A previously reported restricted stock unit award granted on May 25, 2023 vested on July 15, 2026 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on June 30, 2026 was not less than the closing price on May 25, 2023 and (ii) MannKind's total shareholder return (TSR) over the period from May 23, 2023 to June 30, 2026 was at the 41.5th percentile of the TSR of the Russell 3000 Pharmaceutical Biotechnology Index over the same period. As a result, the performance objective was achieved at 83% of target, resulting in a total share delivery of 93,790 shares. The acquisition of 113,000 shares pursuant to the restricted stock award was reported in Table II of the Form 4 filed by the Reporting Person on May 26, 2023. The remaining 19,210 shares were forfeited in accordance with the performance vesting criteria.
Open filing 0001193125-26-308129 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-17Marasco Dominic Officer: Pres, Endocrine Business Unit
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $0.01 Par Value
Disposed (D)3,6234.09
14,818.07

Derived: shares × price per share. Exact value 14818.07.

343,398Direct (D) No
F1, F2
  • F1 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
  • F2 Includes 2,775 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2026.
Open filing 0001193125-26-308137 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22Shannon James Samuel Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Unit — underlying Common Stock, $0.01 Par Value (82,781)
Acquired (A)82,7810—82,781Direct (D) No
F2, F3
  • F2 Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
  • F3 Restricted stock unit vested on May 20, 2026, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation.
Open filing 0001193125-26-237430 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22Shannon James Samuel Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Unit — underlying Common Stock, $0.01 Par Value (16,556)
Acquired (A)16,5560—16,556Direct (D) No
F2, F4
  • F2 Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
  • F4 Award granted in lieu of annual cash retainer payment for non-employee directors. Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service from the board of directors of MannKind Corporation.
Open filing 0001193125-26-237430 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22Kay Sabrina Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Unit — underlying Common Stock, $0.01 Par Value (82,781)
Acquired (A)82,7810—82,781Direct (D) No
F2, F3
  • F2 Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
  • F3 Restricted stock unit vested on May 20, 2026, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation.
Open filing 0001193125-26-237424 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22MUNDKUR CHRISTINE Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Unit — underlying Common Stock, $0.01 Par Value (82,781)
Acquired (A)82,7810—82,781Direct (D) No
F2, F3
  • F2 Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
  • F3 Restricted stock unit vested on May 20, 2026, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation.
Open filing 0001193125-26-237426 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22Friedman Michael A Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Unit — underlying Common Stock, $0.01 Par Value (82,781)
Acquired (A)82,7810—82,781Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
  • F2 Restricted stock unit vested on May 20, 2026, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation.
Open filing 0001193125-26-237456 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22Binder Steven B. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Unit — underlying Common Stock, $0.01 Par Value (82,781)
Acquired (A)82,7810—82,781Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
  • F2 Restricted stock unit vested on May 20, 2026, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation.
Open filing 0001193125-26-237438 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22Grancio Jennifer Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Unit — underlying Common Stock, $0.01 Par Value (82,781)
Acquired (A)82,7810—82,781Direct (D) No
F2, F3
  • F2 Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
  • F3 Restricted stock unit vested on May 20, 2026, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation.
Open filing 0001193125-26-237432 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22HOOPER ANTHONY C Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Unit — underlying Common Stock, $0.01 Par Value (82,781)
Acquired (A)82,7810—82,781Direct (D) No
F1, F2
  • F1 Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
  • F2 Restricted stock unit vested on May 20, 2026, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation.
Open filing 0001193125-26-237431 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22HOOPER ANTHONY C Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Unit — underlying Common Stock, $0.01 Par Value (16,556)
Acquired (A)16,5560—16,556Direct (D) No
F1, F3
  • F1 Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
  • F3 Award granted in lieu of annual cash retainer payment for non-employee directors. Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service from the board of directors of MannKind Corporation.
Open filing 0001193125-26-237431 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22Tross Stuart A Officer: Chief People Workpl Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $0.01 Par Value
Acquired (A)33,8982.95
99,999.1

Derived: shares × price per share. Exact value 99999.10.

1,026,122Direct (D) No
F1
  • F1 The securities were purchased through the Issuer's Market Price Stock Purchase Plan effective May 29, 2018. The purchase was approved by the Company's Board of Directors on May 20, 2026.
Open filing 0001193125-26-237429 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22Consiglio Ronald J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $0.01 Par Value
Acquired (A)10,0002.95
29,500

Derived: shares × price per share. Exact value 29500.00.

132,342Direct (D) No
F1, F2
  • F1 The securities were purchased through the Issuer's Market Price Stock Purchase Plan effective May 29, 2018. The purchase was approved by the Company's Board of Directors on May 20, 2026.
  • F2 423,655 shares representing deferred restricted stock units were inadvertently included in Table I holdings on prior filings.
Open filing 0001193125-26-237444 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22Consiglio Ronald J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Unit — underlying Common Stock, $0.01 Par Value (82,781)
Acquired (A)82,7810—82,781Direct (D) No
F3, F4
  • F3 Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
  • F4 Restricted stock unit vested on May 20, 2026, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation.
Open filing 0001193125-26-237444 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22Consiglio Ronald J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Unit — underlying Common Stock, $0.01 Par Value (16,556)
Acquired (A)16,5560—16,556Direct (D) No
F3, F5
  • F3 Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
  • F5 Award granted in lieu of annual cash retainer payment for non-employee directors. Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service from the board of directors of MannKind Corporation.
Open filing 0001193125-26-237444 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,793 filings read, the latest filed 2026-11-17. Prior quarter ending 2026-06-30: 9,164 filings read.

Showing 1–50 of 260

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
BlackRock, Inc. Partly reported under another manager32,919,459 SH128,385,889 dollarsHigher by 786,236 Prior quarter: 32,133,223Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
Rubric Capital Management LP 29,430,000 SH114,777,000 dollarsHigher by 11,430,000 Prior quarter: 18,000,000Open filing 0001104659-26-128244 Filed 2026-11-16 Dispute this row
Frazier Life Sciences Management, L.P. 15,755,491 SH61,446,415 dollarsHigher by 9,155,491 Prior quarter: 6,600,000Open filing 0001892134-26-000007 Filed 2026-11-16 Dispute this row
STATE STREET CORP Partly reported under another manager15,096,712 SH58,877,177 dollarsLower by 1,077,331 Prior quarter: 16,174,043Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 14,167,827 SH55,254,525 dollarsHigher by 998,435 Prior quarter: 13,169,392Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager8,052,721 SH31,411,927 dollarsHigher by 105,518 Prior quarter: 7,947,203Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
Deep Track Capital, LP 5,030,522 SH19,619,036 dollarsLower by 969,478 Prior quarter: 6,000,000Open filing 0001856083-26-000006 Filed 2026-11-16 Dispute this row
180 WEALTH ADVISORS, LLC 4,986,096 SH19,445,774 dollarsHigher by 26,745 Prior quarter: 4,959,351Open filing 0001730817-26-000005 Filed 2026-11-03 Dispute this row
FMR LLC Partly reported under another manager4,539,873 SH17,705,506 dollarsHigher by 438,827 Prior quarter: 4,101,046Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
TSP Capital Management Group, LLC 4,180,525 SH16,304,048 dollarsHigher by 207,850 Prior quarter: 3,972,675Open filing 0001172661-26-004556 Filed 2026-10-15 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager3,143,351 SH12,259,069 dollarsHigher by 988,852 Prior quarter: 2,154,499Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 3,114,689 SH12,147,287 dollarsHigher by 112,520 Prior quarter: 3,002,169Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager2,910,442 SH11,350,724 dollarsHigher by 23,152 Prior quarter: 2,887,290Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 2,868,750 SH11,188,125 dollarsHigher by 270,023 Prior quarter: 2,598,727Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
MORGAN STANLEY Partly reported under another manager2,772,111 SH10,811,234 dollarsLower by 702,759 Prior quarter: 3,474,870Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
TWO SIGMA INVESTMENTS, LP 2,482,530 SH9,681,867 dollarsLower by 211,182 Prior quarter: 2,693,712Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row
VANGUARD FIDUCIARY TRUST CO 2,297,665 SH8,960,894 dollarsHigher by 100,886 Prior quarter: 2,196,779Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
UBS Group AG Partly reported under another manager2,226,693 SH8,684,103 dollarsLower by 659,538 Prior quarter: 2,886,231Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
FIRST TRUST ADVISORS LP 1,871,932 SH7,300,534 dollarsNot in the prior quarter’s filings read Open filing 0001445546-26-008622 Filed 2026-11-12 Dispute this row
Woodline Partners LP 1,830,378 SH7,138,474 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager1,664,297 SH6,490,759 dollarsLower by 700,575 Prior quarter: 2,364,872Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
AQR CAPITAL MANAGEMENT LLC Partly reported under another manager1,439,895 SH5,615,591 dollarsLower by 2,368,929 Prior quarter: 3,808,824Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row
Janus Henderson Group Ltd. Partly reported under another manager1,399,278 SH5,457,824 dollarsNot in the prior quarter’s filings read Open filing 0001085146-26-000952 Filed 2026-11-16 Dispute this row
AMERIPRISE FINANCIAL INC Partly reported under another manager1,370,808 SH5,346,152 dollarsHigher by 1,357,870 Prior quarter: 12,938Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row
Point72 Asset Management, L.P. 1,219,663 SH4,756,686 dollarsNot in the prior quarter’s filings read Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row
J. Goldman Co LP 1,173,696 SH4,577,414 dollarsHigher by 357,107 Prior quarter: 816,589Open filing 0001412741-26-000004 Filed 2026-11-16 Dispute this row
WELLS FARGO COMPANY/MN Partly reported under another manager934,852 SH3,645,923 dollarsLower by 541,561 Prior quarter: 1,476,413Open filing 0000072971-26-000342 Filed 2026-11-16 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager925,065 SH3,607,753 dollarsHigher by 26,602 Prior quarter: 898,463Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
MILLENNIUM MANAGEMENT LLC 920,001 SH3,588,004 dollarsHigher by 488,875 Prior quarter: 431,126Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
BOOTHBAY FUND MANAGEMENT, LLC 897,129 SH3,498,803 dollarsNot in the prior quarter’s filings read Open filing 0001549230-26-000012 Filed 2026-11-16 Dispute this row
VOYA INVESTMENT MANAGEMENT LLC Partly reported under another manager737,655 SH2,876,854 dollarsHigher by 524,726 Prior quarter: 212,929Open filing 0001068837-26-000006 Filed 2026-11-10 Dispute this row
DELTEC ASSET MANAGEMENT LLC 728,000 SH2,839,200 dollarsNot in the prior quarter’s filings read Open filing 0000919574-26-007190 Filed 2026-10-26 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager717,124 SH2,796,784 dollarsLower by 463,679 Prior quarter: 1,180,803Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
Nuveen, LLC Partly reported under another manager650,922 SH2,538,596 dollarsHigher by 15,190 Prior quarter: 635,732Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
DIADEMA PARTNERS LP 604,025 SH2,355,698 dollarsHigher by 588,022 Prior quarter: 16,003Open filing 0001892688-26-000170 Filed 2026-11-16 Dispute this row
Swiss National Bank 587,400 SH2,290,860 dollarsUnchanged Prior quarter: 587,400Open filing 0001582202-26-000008 Filed 2026-11-12 Dispute this row
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Partly reported under another manager539,398 SH2,103,652 dollarsHigher by 2,264 Prior quarter: 537,134Open filing 0000861177-26-000005 Filed 2026-11-16 Dispute this row
1492 Capital Management LLC 517,313 SH2,017,521 dollarsHigher by 35,591 Prior quarter: 481,722Open filing 0001584087-26-000009 Filed 2026-11-12 Dispute this row
STATE OF WISCONSIN INVESTMENT BOARD 512,539 SH1,998,902 dollarsHigher by 1,494 Prior quarter: 511,045Open filing 0001062993-26-006051 Filed 2026-11-16 Dispute this row
Jump Financial, LLC Partly reported under another manager496,320 SH1,935,648 dollarsHigher by 338,349 Prior quarter: 157,971Open filing 0000905148-26-004786 Filed 2026-11-13 Dispute this row
Squarepoint Ops LLC Partly reported under another manager496,150 SH1,934,985 dollarsHigher by 83,088 Prior quarter: 413,062Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row
PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager473,172 SH1,846 dollarsHigher by 1,587 Prior quarter: 471,585Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row
Schonfeld Strategic Advisors LLC 441,272 SH1,720,960 dollarsHigher by 24,789 Prior quarter: 416,483Open filing 0001665241-26-000003 Filed 2026-11-16 Dispute this row
ALPS ADVISORS INC 426,020 SH1,661,478 dollarsHigher by 113,669 Prior quarter: 312,351Open filing 0001398344-26-019318 Filed 2026-11-03 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager414,600 SH1,616,940 dollarsHigher by 129,100 Prior quarter: 285,500Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager397,240 SH1,549,236 dollarsLower by 499,020 Prior quarter: 896,260Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
ExodusPoint Capital Management, LP 394,608 SH1,538,971 dollarsHigher by 3,467 Prior quarter: 391,141Open filing 0001736225-26-000013 Filed 2026-11-16 Dispute this row
RHUMBLINE ADVISERS 365,205 SH1,424,289 dollarsLower by 11,476 Prior quarter: 376,681Open filing 0001115418-26-000015 Filed 2026-11-10 Dispute this row
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 343,145 SH1,338,266 dollarsLower by 27,088 Prior quarter: 370,233Open filing 0001081019-26-000023 Filed 2026-11-13 Dispute this row
BARCLAYS PLC Partly reported under another manager341,143 SH1,330,458 dollarsHigher by 92,646 Prior quarter: 248,497Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • WELLINGTON MANAGEMENT GROUP LLP 7,844,807 SH
  • BRAIDWELL LP 3,458,429 SH
  • Sixth Street Partners Management Company, L.P. 2,598,727 SH
  • Caption Management, LLC 1,000,000 SH
  • SCOPIA CAPITAL MANAGEMENT LP 694,961 SH
  • Jupiter Topco LLC 591,665 SH
  • Jefferies Financial Group Inc. 397,700 SH
  • Caption Management, LLC 331,979 SH
  • ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 319,066 SH
  • Stonepine Capital Management, LLC 250,000 SH
  • SG Americas Securities, LLC 174,228 SH
  • TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 161,300 SH
  • TUDOR INVESTMENT CORP ET AL 150,389 SH
  • Susquehanna Portfolio Strategies, LLC 134,868 SH
  • NEW YORK STATE COMMON RETIREMENT FUND 84,499 SH
  • Aquatic Capital Management LLC 78,709 SH
  • Sequoia Financial Advisors, LLC 69,703 SH
  • Painted Porch Advisors LLC 53,432 SH
  • WINTON GROUP Ltd 46,300 SH
  • SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 43,040 SH
  • Freestone Capital Holdings, LLC 29,093 SH
  • Fulcrum Asset Management LLP 29,056 SH
  • SWAN Capital LLC 28,850 SH
  • RENAISSANCE TECHNOLOGIES LLC 27,697 SH
  • MCF Advisors LLC 25,110 SH
  • Virtu Financial LLC 23,219 SH
  • Wellington Shields Co., LLC 22,660 SH
  • CANADA PENSION PLAN INVESTMENT BOARD 21,100 SH
  • Brevan Howard Capital Management LP 20,665 SH
  • ACADIAN ASSET MANAGEMENT LLC 20,014 SH
  • Discipline Wealth Solutions, LLC 18,293 SH
  • Integrated Wealth Concepts LLC 18,264 SH
  • INCEPTIONR LLC 15,979 SH
  • Parcion Private Wealth LLC 15,709 SH
  • Pallas Capital Advisors LLC 13,978 SH
  • Summit Global Investments 13,901 SH
  • Krilogy Financial LLC 13,135 SH
  • Caerus Investment Advisors, LLC 11,129 SH
  • Corient Private Wealth LP 10,988 SH
  • Quantbot Technologies LP 10,284 SH
  • Pacer Advisors, Inc. 3,954 SH
  • Crews Bank Trust 2,648 SH
  • ATWOOD PALMER INC 2,000 SH
  • Optiver Holding B.V. 575 SH
  • Wealth Enhancement Trust Services, Inc. 370 SH
  • Blume Capital Management, Inc. 100 SH
  • JPMORGAN CHASE CO 100 SH
  • RMG Wealth Management LLC 50 SH
  • Silver Grove Financial Group, Inc. 27 SH
  • Hughes Financial Services, LLC 2 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
STATE STREET CORPORATION COMMON STOCK4.715,096,712.0009/30/2026 Filed 2026-11-10SCHEDULE 13GOpen filing 0000093751-26-000688 Dispute this row
Rubric Capital Management LP Common Stock, $0.01 par value per share5.8318,000,000.0006/30/2026 Filed 2026-08-14SCHEDULE 13GOpen filing 0001104659-26-097084 Dispute this row
David Rosen Common Stock, $0.01 par value per share5.8318,000,000.0006/30/2026 Filed 2026-08-14SCHEDULE 13GOpen filing 0001104659-26-097084 Dispute this row
Vanguard Capital Management Common Stock515,450,42106/30/2026 Filed 2026-07-31SCHEDULE 13GOpen filing 0002100119-26-001503 Dispute this row
STATE STREET CORPORATION COMMON STOCK6.118,683,483.0003/31/2026 Filed 2026-05-12SCHEDULE 13GOpen filing 0000093751-26-000262 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-27SCHEDULE 13G/AAmendment 4Open filing 0000102909-26-001801 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,241,199 filings read, dated 2004-06-14 to 2026-11-16: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
20151
2016204,322
2017202,494
2018202,048
2019193,638
2020144,184
2021224,474
2022158,941
2023199,811
2024209,823
2025235,520
2026260,165

Filings made before the SEC required XML are listed, not extracted.

Back to MannKind Corporation